Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients

Keyphrases

• Tumor Necrosis Factor-α 100%
• Off-label Use 100%
• Retrospective Survey 100%
• University Departments 100%
• Alpha Inhibitors 100%
• Psoriatic Arthritis 25%
• Severe Adverse Effects 25%
• Mucocutaneous Diseases 25%
• Remission 12%
• Medical Records 12%
• Patient Selection 12%
• Sarcoidosis 12%
• Genital 12%
• Hidradenitis Suppurativa 12%
• Pyoderma Gangrenosum 12%
• Benefit-risk Assessment 12%
• Chronic Urticaria 12%
• Pustulosis 12%
• Folliculitis Decalvans 12%
• Acne Conglobata 12%
• Dissecting Cellulitis of the Scalp 12%
• Aphthous Stomatitis 12%
• Granuloma Annulare 12%
• Granuloma Faciale 12%
• Aphthous Lesions 12%
• Sweet Syndrome 12%
• Wells Syndrome 12%
• Lichen Planus 12%
• Pustular Psoriasis 12%
• Orofacial Granulomatosis 12%
• Familial Benign Chronic Pemphigus 12%
• Granulomatous Rosacea 12%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Off-Label Use 100%
• Disease 25%
• Adverse Event 25%
• Sarcoidosis 12%
• Granulomatosis 12%
• Psoriasis 12%
• Psoriatic Arthritis 12%
• Aphthous Stomatitis 12%
• Pyoderma gangrenosum 12%
• Hidradenitis Suppurativa 12%
• Chronic Urticaria 12%
• Pustulosis 12%
• Rhinophyma 12%
• Acute Febrile Neutrophilic Dermatosis 12%
• Granuloma Annulare 12%
• Orofacial Granulomatosis 12%
• Dissecting Cellulitis of the Scalp 12%
• Lichen Planus 12%
• Granuloma Faciale 12%
• Folliculitis Decalvans 12%
• Acne Conglobata 12%
• Eosinophilic Cellulitis 12%
• Hailey-Hailey Disease 12%